Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
Published 1 month ago
Description
In today’s Pharmaceutical Executive Daily, Eli Lilly enters a $7 billion agreement to acquire Kelonia Therapeutics, the Trump administration issues an executive order to accelerate FDA reviews of psychedelic therapies, and Lilly’s oral weight loss pill sees strong early prescribing demand.